Last updated: about 1 year ago
Protagonist Therapeutics Q4 2024 Report: A Financial Turnaround Worth Watching
Explore Protagonist Therapeutics' Q4 2024 financial report showcasing $434.4M revenue, $275.2M net income, and a strong 'Buy' recommendation for investors seeking growth in biotech.